Titlebook: Cancer Immunology; Bench to Bedside Imm Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

overrule

f cancers, with a focus on clinical aspects.Describes in depThis translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The sco

Anhydrous

Dna262

燒瓶

激勵(lì)

Monoclonal Antibodies for Cancer Immunotherapy,rapeutic mAbs entails gaining in-depth knowledge about factors including antibody structure and function, the properties of an ideal tumor antigen, the advantages of employing combinational therapies, and the limitations of antibody-based modalities. This chapter concentrates on mAbs as versatile platforms for cancer immunotherapy.

Ancillary

Book 20151st editionin the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem ce

蚊帳

Ger J. van der Vusse,Robert S. Renemantherapeutic options to a broad range of malignancies. This chapter will review the rationale for targeting immune checkpoints, the pathways of particular interest, and the research being conducted to bring checkpoint blockade to clinical use.

AMEND

HALL

Overcoming Cancer Tolerance with Immune Checkpoint Blockade,therapeutic options to a broad range of malignancies. This chapter will review the rationale for targeting immune checkpoints, the pathways of particular interest, and the research being conducted to bring checkpoint blockade to clinical use.

Infusion

Toll-Like Receptor Pathway and its Targeting in Treatment of Cancers,e TLR function varies according to the cancer type and the TLRs expressed, their signaling pathway should either be triggered or targeted to control cancer progression. Hence, more investigations are required to discover proper therapeutic approaches for cancer.